These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4962524)

  • 61. Chemoresistance to Isoxyl. Its determination and its evaluation.
    Muzikravić T
    Antibiot Chemother; 1970; 16():177-81. PubMed ID: 4108884
    [No Abstract]   [Full Text] [Related]  

  • 62. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
    Irtuganova OA; Smirnova NS; Slogotskaia LV
    Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
    [No Abstract]   [Full Text] [Related]  

  • 64. [Clinical and bacteriological correlations in 90 autopsies of tubercular children].
    Lupaşcu I; Algeorge G; Teodosiu-Fierbinţeanu O; Petre A
    Pediatria (Bucur); 1970; 19(1):57-63. PubMed ID: 4986857
    [No Abstract]   [Full Text] [Related]  

  • 65. [Impact of drug resistance on the fitness of Mycobacteruim tuberculosis of the genotype W-Beijing].
    Tungusova OS; Mar'iandyshev AO; Kaugant DA; Sandven P; Bjeune G
    Probl Tuberk Bolezn Legk; 2005; (8):46-50. PubMed ID: 16209021
    [No Abstract]   [Full Text] [Related]  

  • 66. Susceptibility of tubercle myobacteria to antibacterial drugs and its importance for the clinical course of tuberculosis.
    Radanov R; Dobrev P; Kalfin E
    Nauchni Tr Vissh Med Inst Sofiia; 1965; 44(5):27-35. PubMed ID: 4223179
    [No Abstract]   [Full Text] [Related]  

  • 67. [Significance of mycobacterial drug resistance in pulmonary tuberculosis surgery].
    Repin IuM; Avetisian AO; El'kin AV; Otten TF; Riasnianskaia TE; Trofimov MA
    Probl Tuberk; 2001; (9):6-10. PubMed ID: 11858098
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates].
    Zhukova MP
    Probl Tuberk; 1998; (4):4-5. PubMed ID: 9771024
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is second-line anti-tuberculosis drug susceptibility testing reliable?
    Kim SJ; Espinal MA; Abe C; Bai GH; Boulahbal F; Fattorin L; Gilpin C; Hoffner S; Kam KM; Martin-Casabona N; Rigouts L; Vincent V
    Int J Tuberc Lung Dis; 2004 Sep; 8(9):1157-8. PubMed ID: 15455606
    [No Abstract]   [Full Text] [Related]  

  • 70. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Short-course chemotherapy of pulmonary tuberculosis and several problems concerning its use, especially in India].
    Fox W
    Bull Int Union Tuberc; 1985; 60(1-2):44-54. PubMed ID: 3935193
    [No Abstract]   [Full Text] [Related]  

  • 72. [Evaluation of secondary chemoresistance of Koch bacillus at the present time].
    Jemna I; Lego I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):243-4. PubMed ID: 6278569
    [No Abstract]   [Full Text] [Related]  

  • 73. [Considerations on drug-resistent tuberculosis patients admitted to G. Saint-Bois Hospital during the years 1966 to 1970].
    Piñeyro JA; Bazerque E; Fossemalle JR; Tarallo NH
    Hoja Tisiol; 1971; 28(1-2):77-88. PubMed ID: 5006266
    [No Abstract]   [Full Text] [Related]  

  • 74. [Primary resistance of the tubercle bacillus to antibiotics. Bacteriological and therapeutic study. Apropos of 22 cases].
    Weill G; Levy A; Guignon JP; Petion G; Lecoq H
    Strasb Med; 1965 Mar; 16(3):165-93. PubMed ID: 4953251
    [No Abstract]   [Full Text] [Related]  

  • 75. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract]   [Full Text] [Related]  

  • 76. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P
    Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 78. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 79. [Drug resistance of Mycobacterium tuberculosis in coniotuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Lastkov OA
    Vrach Delo; 1981 Aug; (8):72-4. PubMed ID: 6791383
    [No Abstract]   [Full Text] [Related]  

  • 80. Cross-resistance amongst thiambutosine, thiacetazone, ethionamide and prothionamide with Mycobacterium leprae.
    Pattyn SR; Colston MJ
    Lepr Rev; 1978 Dec; 49(4):324-6. PubMed ID: 84317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.